Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 911Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 2Clarinex

02 4Clarinex

PharmaCompass

01

Brand Name : Clarinex

Desloratadine

arrow
Fi Europe 2024
Not Confirmed

Brand Name : Clarinex

arrow
Fi Europe 2024
Not Confirmed

Desloratadine

Main Therapeutic Indication : Respiratory Disorders

Currency : USD

2021 Revenue in Millions : 111

2020 Revenue in Millions : 130

Growth (%) : -15

blank

02

Brand Name : Clarinex

Desloratadine

arrow
Fi Europe 2024
Not Confirmed

Brand Name : Clarinex

arrow
Fi Europe 2024
Not Confirmed

Desloratadine

Main Therapeutic Indication : Respiratory Diseases

Currency : USD

2022 Revenue in Millions : 125

2021 Revenue in Millions : 111

Growth (%) : 13

blank

03

Brand Name : Clarinex

Desloratadine

arrow
Fi Europe 2024
Not Confirmed

Brand Name : Clarinex

arrow
Fi Europe 2024
Not Confirmed

Desloratadine

Main Therapeutic Indication : Respiratory Diseases

Currency : USD

2023 Revenue in Millions : 136

2022 Revenue in Millions : 125

Growth (%) : 9

blank

04

Brand Name : Clarinex

Desloratadine

arrow
Fi Europe 2024
Not Confirmed

Brand Name : Clarinex

arrow
Fi Europe 2024
Not Confirmed

Desloratadine

Main Therapeutic Indication : Immunology (Organ Transplant, Arthr...

Currency : USD

2015 Revenue in Millions : 232

2014 Revenue in Millions : 187

Growth (%) : -19%

blank

05

Brand Name : Clarinex

Desloratadine

arrow
Fi Europe 2024
Not Confirmed

Brand Name : Clarinex

arrow
Fi Europe 2024
Not Confirmed

Desloratadine

Main Therapeutic Indication : Immunology (Organ Transplant, Arthr...

Currency : USD

2014 Revenue in Millions : -1.30%

2013 Revenue in Millions :

Growth (%) :

blank

06

Brand Name : Clarinex

Desloratadine

arrow
Fi Europe 2024
Not Confirmed

Brand Name : Clarinex

arrow
Fi Europe 2024
Not Confirmed

Desloratadine

Main Therapeutic Indication : Immunology (Organ Transplant, Arthr...

Currency : USD

2016 Revenue in Millions : Not Reported

2015 Revenue in Millions : 187

Growth (%) : -100

blank